LENZ Therapeutics, Inc. (LENZ)
4.52
-0.20
(-4.24%)
USD |
NASDAQ |
Sep 11, 16:00
4.52
0.00 (0.00%)
After-Hours: 06:44
LENZ Therapeutics Price to Book Value : 0.6476 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.6476 |
| September 10, 2026 | 0.6763 |
| September 09, 2026 | 0.7035 |
| September 08, 2026 | 0.7637 |
| September 04, 2026 | 0.854 |
| September 03, 2026 | 0.8354 |
| September 02, 2026 | 0.8311 |
| September 01, 2026 | 0.7494 |
| August 31, 2026 | 0.7465 |
| August 28, 2026 | 0.7322 |
| August 27, 2026 | 0.6892 |
| August 26, 2026 | 0.6849 |
| August 25, 2026 | 0.6691 |
| August 24, 2026 | 0.6577 |
| August 21, 2026 | 0.6706 |
| August 20, 2026 | 0.6677 |
| August 19, 2026 | 0.705 |
| August 18, 2026 | 0.6835 |
| August 17, 2026 | 0.6863 |
| August 14, 2026 | 0.6777 |
| August 13, 2026 | 0.6591 |
| August 12, 2026 | 0.7222 |
| August 11, 2026 | 0.7465 |
| August 10, 2026 | 0.768 |
| August 07, 2026 | 0.768 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.7479 |
| August 05, 2026 | 0.7551 |
| August 04, 2026 | 0.7236 |
| August 03, 2026 | 0.7157 |
| July 31, 2026 | 0.7594 |
| July 30, 2026 | 0.8253 |
| July 29, 2026 | 0.8196 |
| July 28, 2026 | 0.8425 |
| July 27, 2026 | 0.8167 |
| July 24, 2026 | 0.7852 |
| July 23, 2026 | 0.7236 |
| July 22, 2026 | 0.7651 |
| July 21, 2026 | 0.7393 |
| July 20, 2026 | 0.7107 |
| July 17, 2026 | 0.7422 |
| July 16, 2026 | 0.6992 |
| July 15, 2026 | 0.715 |
| July 14, 2026 | 0.7064 |
| July 13, 2026 | 0.7494 |
| July 10, 2026 | 0.801 |
| July 09, 2026 | 0.8296 |
| July 08, 2026 | 0.8783 |
| July 07, 2026 | 0.8454 |
| July 06, 2026 | 0.8024 |
| July 02, 2026 | 0.8439 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Impact BioMedical, Inc. | 4.609 |
| Enveric Biosciences, Inc. | 0.6915 |
| Ocular Therapeutix, Inc. | 4.429 |
| Liquidia Corp. | 30.48 |
| Aquestive Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 6.437 |
| PEG Ratio | -0.0096 |
| Price | 4.52 |
| Earnings Yield | -90.29% |
| Market Cap | 142.00M |
| PEGY Ratio | -0.0096 |